Morning Keynote Address: “Connecting Healthcare”

Jean-Christophe Tellier
Chief Executive Officer, UCB, Inc.


Jean-Christophe Tellier joined UCB in 2011. He became UCB’s Chief Executive Officer on January 1, 2015 after having successfully led UCB’s BioBrands and Solutions division as Executive Vice President.

He is a member of the Board of Directors of UCB, President of the Board of the European Federation of Pharmaceutical Associations (EFPIA), a member of the Board of PhRMA (Pharmaceutical Research and Manufacturers of America) and a member of the Board of WELBIO (Walloon Institute for Life Lead Sciences).

Jean-Christophe Tellier is an experienced global leader. He was trained as a Medical Doctor and specialized in rheumatology. He has built a distinguished 30-year career in the biopharmaceutical industry, taking on different global leadership responsibilities in different parts of the world.

His patient-centric approach, his passion for science, combined with his strategic and operational skills, have allowed him to significantly contribute to UCB’s success in recent years.

For Jean-Christophe “engaging the patient in our vision is the best way for our company to be successful in the long term. Having a holistic view of a patient, of his/her life in his/her environment is essential to ensure effective treatment”. Jean-Christophe also believes that “all healthcare players - physicians, payors, carers, industry and academia - should cooperate even more effectively and become stronger partners sharing a same goal: improving patient care”.

As a leader, Jean-Christophe has always had a passion for developing people, which he sees as “a key force to drive company success”. His ambition is to continue to further engage UCB teams behind the company’s vision and fully leverage UCB’s strong culture and talents.

Fireside Chat: "Empowering the Patient"

Kornelius Bankston
Managing Partner at techPLUG


Kornelius is the managing partner of techPLUG. He leads the firm’s strategy and business development efforts. He’s a graduate of Morehouse College (BSc. Chemistry), Emory University (MSc. Biomolecular Chemistry) and the Georgia Institute of Technology (MBA- Management of Technology). Korrnelius is a lead partner with the Intentionally Good Project and a board member of Southeast BIO.


After graduating from Emory University, Kornelius worked for a startup founded by Dr. Dennis Liotta as a business development intern. He went on to become a project manager with the Georgia Department of Economic Development where he worked to help recruit Baxter (now known as Takeda) to Georgia. He moved on to manage Morehouse School of Medicine’s first Office of Technology Transfer and Office of Industry Sponsored Clinical trials.  He was able to help underserved populations who traditionally do not participate in clinical trials to become more engaged in clinical research. Kornelius served as the director of bioscience ecosystem expansion for the Metro Atlanta Chamber where he worked to recruit bioscience companies to the Metro Atlanta region.  While at the Metro Atlanta Chamber he launched Global Health ATL,, to promote Atlanta as the Center for Global Health. Most recently, Kornelius served as the director of business development for Color Genomics leading the company’s southeast business development efforts.  Color Genomics is a Silicon Valley based biotech company.

Jen Martin Hall
Senior Vice President, Corporate Communications, Sharecare


Jen Martin Hall is senior vice president of corporate communications at Sharecare, the digital health company founded to help each person – no matter where they are in their health journey – build a longer, better life by enabling health transformation at the individual, organizational and community level. Based at the company’s global headquarters in Atlanta, Martin Hall leads the company’s strategic communications efforts, including media relations, internal communications, community relations and reputation management, and plays a key role in brand strategy and product marketing.

Previously, Martin Hall worked in corporate communications for Apple, where she focused on publicity for iPad, iOS and iCloud, and oversaw broadcast press relations at the company’s launch events and Worldwide Developers Conferences. While at Apple, Martin Hall also helped plan and execute global launches for a variety of the company’s marquee hardware and software products, including iPhone, iPad, iOS and iCloud.

Prior to Apple, Martin Hall worked for CNN Worldwide, where she led publicity for the network’s digital platforms and the communications strategy for the company’s movement into new media, virtual worlds, social networking and user-generated content.

Earlier in her career, Martin Hall served as the principal adviser for a number of technology-driven start-ups, government organizations and universities. She also provided public relations, reputation management and crisis communications counsel to various technology and consumer products clients while working at public relations agencies including GCI Group, Weber Shandwick Worldwide and Edelman Public Relations.

Over the years, Martin Hall’s accomplishments have gained her recognition by PRWeek as a Top 40 Under 40 honoree, Women in Cable Telecommunications as one of the top 40 rising leaders in the industry, and PRNews for Social Media Campaign of the Year. With bachelor’s degrees in philosophy and political science from the University of Georgia, she also is active in the community, serving on the board of directors for Women in Technology (WIT) and the advisory board for the Chattahoochee Riverkeeper.

Jayne Morgan, MD
Director of Innovation and Research Development, Piedmont Healthcare

Jayne Morgan, M.D. is a Cardiologist and the Director of Innovation at the Piedmont Healthcare Corporation in Atlanta, GA.  Within this role she is accountable for building an Innovation network within Piedmont, and democratizing innovation by identifying and aligning opportunities within the system for technology development and/or process improvement. She is also responsible for setting the vision, trajectory, and long term strategic scaling and sustainability for the Office of Innovation, as well as seeking key partnerships and stakeholders to progress these goals.  Further, she is tasked with providing the internal infrastructure of the Office of Innovation, including the development of a systemwide Intellectual Property Policy, plus all needed contracts and templates. And finally, she serves to support the development of any and all internal Intellectual Property of Piedmont employees, and progress these projects within the incubator toward licensing or commercialization potential.   

Prior to this role she had a split role as both the Director of Innovation and Director of Research Development where she had responsibility for the strategic growth of the Piedmont Research Institute, the development of the long range strategic vision for research programs across all medical specialties, and contract negotiations for all new partners. Dr. Morgan initially came to Piedmont in 2015 as the Director of Cardiovascular Research for the Piedmont Heart Institute. Within this role, she implemented a new business model focused on system integration, contracts, staff re-alignments, portfolio diversification, and strategic growth realizing steadily increasing revenue earnings that have continued to this day. While in this role, she both expanded research to other hospital facilities, and began the first Feasibility Program which has served as the nidus via which Piedmont has been able to reach worldwide status within Structural and Valvular Heart, including the #1 Center in the United States for transcatheter tricuspid therapy.  

Prior to coming to Piedmont, Dr. Morgan served as the Chief Medical Officer of the American Chemistry Council (where she developed a new translational research program), a Cardiology Consultant at Abbott Vascular Devices Structural Heart Division (working with the Mitra-Clip team/U.S. and Europe), the World Wide Director of the Cardiorenal Drug Development program at Solvay Pharmaceuticals, and an Assistant Professor of Medicine at the Cleveland Clinic.  

Dr. Morgan currently serves as the President Elect of the Southeastern Medical Device Association (SEMDA), Co-Chair of the Health and Human Services Conference 2021, Founding Board Member of MedTech Women, Co-Chair of the BioScience Leadership Council at the Metro Atlanta Chamber of Commerce, Board Member of the American Heart Association/Atlanta Chapter, the National Board Member of The American Heart Association Technology Team, the Regional Board Member of The American Heart Association Health Equity Committee, and is an active member of BioMed Investors Network. 

Dr. Morgan completed her B.S. degree at Spelman College (C’84), Medical Degree at Michigan State University, Internal Medicine Residency at George Washington University, and both her Cardiology and Pacemaker Fellowship at Mount Sinai Medical Center.


Luncheon Keynote Address: "Personalized Health in a Chaotic Environment"

Marc M. Boutin, JD
Chief Executive Officer, National Health Council


Marc M. Boutin, JD, is the Chief Executive Officer of the National Health Council. He has been a leading voice for greater patient involvement at every stage of the health care continuum, starting with the development of new drugs, to regulatory oversight of health care delivery, to shared decision-making at the point of care. Under his leadership, the National Health Council has convened a broad range of stakeholders to create and effectively implement pragmatic strategies and public policy that address diverse issues, such as enhancing patient engagement, advancing the development of new treatments, and developing a better health delivery system to meet the needs of people with chronic conditions.


Boutin has a long history of board and committee service. Currently he serves as a member of the Patient-Centered Outcomes Research Institute (PCORI) Patient Engagement Advisory Panel, FasterCures Benefit-Risk Advisory Council, and the Medical Device Innovation Consortium (MDIC) Patient-Centered Benefit-Risk Steering Committee.


Boutin has been actively involved in patient advocacy organization management, health advocacy, and both federal and state policy throughout his career. He is a founding member of the international Patient-Focused Medicine Development consortium and has served on the Governing Board of the International Alliance of Patients’ Organizations as a member and treasurer. He is also a former member of the Partnership to Fight Chronic Disease Board of Directors, the Humana Cares Clinical Advisory Board, the eHealth Initiative Leadership Council, Community Health Charities Board of Directors, Healthcare Systems Research Collaboratory, and the North America Advisory Board to the Drug Information Association.

Fireside Chat: "Looking Ahead to 2020 Policy Landscape"

Sheila P. Burke
Strategic Advisor & Chair, Government Relations and Public Policy Group of Baker Donelson


Sheila P. Burke serves as a Senior Public Policy Advisor at Baker DoneIsm) in Washington, D.C.

and Chair of Government Affairs and Public Policy, and is also Adjunct Lecturer in Public

Policy at the Harvard Kennedy School. She served as Executive Dean of the school from 1996-

2000. Previously she had been Chief of Staff to former Senate Majority Leader Bob Dole (1985-

1996), a professional staff member of the Senate Committee on Finance (1979-1982), and

Deputy Staff Director of that committee (1982-1985). She is a member of the National Academy

of Medicine, National Academy of Sciences, and a fellow of the National Academy of Public

Administration and the American Academy of Nursing. She serves on the adjunct faculty at

Georgetown University and is a Distinguished Visitor at the O'Neill Institute for National and

Global Health Law, Georgetown Law Center. She serves on several boards including Ascension

Health, the Commonwealth Fund, Abt, and Chubb. She served as a member of the Medicare

Payment Advisory Commission (2000-2007), and the Kaiser Family Foundation (1999-2008),

serving as chair.

In addition to her government and academic experience, Ms. Burke served as the deputy

secretary and chief operating officer of the Smithsonian Institution, the world's largest museum

and research complex. As the chief operatinL,officer, she had responsibility for the overall

operations of the 19 individual museums and galleries, the National Zoo and nine research

facilities located in Washington, D.C., five states and 150 foreign countries with revenues of

approximately $1 billion and an endowment of $1 billion. During her seven-year tenure at the

Smithsonian, she oversaw the completion of the National Air and Space Museum's Udvar-Hazy

Center, the National Museum of the American Indian and the renovation of the Smithsonian's

Reynolds Center for Art and Portraiture. She was also involved in the initial planning for the

National Museum of African American History and Culture. She began her Smithsonian tenure

in 2000 as the undersecretary for American Museums and National Programs, becoming deputy

secretary and chief operating officer in 2004.

Ms. Burke holds a Master's in Public Administration from Harvard University, a BS in nursing

from the University of San Francisco, and worked as a staff nurse in Berkeley, California.

Crystal Edmonson
Broadcast Editor, Atlanta Business Chronicle


Crystal Edmonson keeps her finger on the pulse of business in Atlanta as Atlanta Business Chronicle’s broadcast editor. She serves as a liaison to the Chronicle’s radio and television partners. Edmonson contributes local, in-depth stories about business and the economy on WABE 90.1 FM, a local NPR affiliate. She also does business reports throughout the day on News Radio 1067 FM and 680 the Fan. She is also the host of the weekly television program Atlanta Business Chronicle’s BIZ, which airs Sundays at 11:00 a.m. on 11Alive.

During the course of her career, Edmonson has covered everything from Washington politics to corporate mergers. She has received several journalism and community honors, including the National Association of Black Journalists Chuck Stone Salute to Excellence Awards for investigative reporting.

A graduate of Emory University, she received a BA in international studies. She then attended Northwestern University, earning an MS in journalism from the Medill School of Journalism.

Since 2005, Edmonson has provided regional leadership for the American City Business Journals’ (ACBJ) summer internship program. Having just completed its 11th year, the program has placed dozens of college students in newspaper internships from San Francisco to Atlanta to Washington, D.C., and a number of students have been hired full time since the program began. Edmonson received the Eagle Award, the ACBJ's highest employee honor, for her leadership of this program. 

She served as president of the Emory Alumni Board in 2008 and helped launch a $1.69 billion fundraising campaign, the university’s largest campaign to date. She continues to volunteer her time and talents to the Emory Alumni Association as well as to other areas of the university.

© 2020 by Georgia Bio. Proudly created with